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Abstract 2-5A-Dependent RNase (RNase L), an important 
component of the 2-5A pathway, is directly implicated in the 
molecular mechanism of interferon action. We have cloned and 
sequenced following immunoscreening, a full-length cDNA that 
encodes the RNase L inhibitor (RLI). Northern blot analysis 
from a variety of human tissues revealed that two transcript 
forms (3.8 kb and 2.4 kb) are ubiquitously expressed but 
differences in levels of expression suggest a tissue-specific 
regulation. The RLI gene was localized to locus 4q31 by in situ 
hybridization indicating that this gene and other enzymes of the 
2-5A pathway are not organized in cluster in the human genome. 
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1. Introduction 
Interferons (IFNs) constitute a family of polypeptides with 
pleiotropic biological effects. IFNs affect a wide variety of 
cellular functions by altering the expression of specific genes 
[1]. They are implicated in the regulation of cell proliferation 
and differentiation, and of the immune response [2,3]. Several 
genes, including those encoding for oligo 2-5A synthetases, 
are regulated by IFNs and involved in the antiviral response. 
These synthetases are activated by double-stranded RNAs, 
frequently found following viral infection, and convert ATP 
into unusual 5'-phosphorylated 2',5'-l inked oligoadenylates 
known as 2-5A [4]. This component activates a unique IFN- 
induced endoribonuclease, the 2-5A-dependent RNase 
(RNase L), capable of degrading both viral and cellular sin- 
gle-stranded RNAs [5,6]. The levels of RNase L and/or 2-5A 
synthetase vary with growth conditions, hormone status, liver 
regeneration and cell differentiation [7-10], suggesting a 
broader role for the 2-5A system in the general control of 
RNA stability. 
Human and murine RNase L cDNAs have been cloned by 
means of ligand screening [11]. The predicted amino acid se- 
quence encoded by this cDNA reveals a repeated phosphate 
loop moti f  (P-loop), a zinc finger motif  homologue and simi- 
larities with protein kinases, zinc fingers and Escherichia coli 
RNase E. Interestingly, the duplicated P-loop has been shown 
to be involved in the binding of 2-5A by deletion analysis and 
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site-directed mutagenesis [11]. It has been proposed that the 2- 
5A-dependent RNase is a heterodimer of a 2-5A binding and 
catalytic subunits [12]. However, on the one hand, study of 
expression of the human 2-5A-dependent RNase in insect cells 
using baculovirus as vector [13] has shown that both the 2-5A 
binding and catalytic domains are encoded by a single cDNA 
expressed as one polypeptide. On the other hand, a recent 
study has shown that the 2-5A-dependent RNase molecules 
dimerize during activation by 2-5A [14]. These findings sug- 
gest a highly complex molecular mechanism for the 2-5A sys- 
tem and the discovery of a new protein acting as a negative 
regulator of the RNase L (referred to RLI  for RNase L in- 
hibitor) has further increased the complexity of this pathway 
[15]. RLI  inhibits binding of 2-5A to endogenous or in vitro 
expressed RNase L in a ratio-dependent and reverse manner. 
This inhibition results neither from competition for 2-5A nor 
from degradation of these components. In addition, RLI  an- 
tagonizes the 2-5A-dependent ucleolytic activity of RNase L 
and overexpression of RLI  in stably transfected HeLa cells 
inhibits both the binding of 2-5A by RNase L and the anti- 
viral activity of IFN. 
We report here the molecular cloning and the chromosomal 
localization of a human cDNA encoding the RNase L inhi- 
bitor. The study of RLI  mRNAs expression has shown that 
two mRNA species of 3.8 and 2.4 kilobases (kb) are expressed 
in various human tissues with a tissue-specific regulation. 
2. Materials and methods 
2.1. Isolation and sequencing of  cDNA 
An MCF7 cell line ~.gtl 1 cDNA library was subjected to immuno- 
screening with the monoclonal antibody BIN (IgM), according to the 
method of Young et al. [16]. The sequence of the positive recombinant 
clone 3~gtl 1 isolated was performed using the Sanger dideoxy method 
(T7 sequencing kit, Pharmacia) and allowed us to identify a 235 bp 
fragment that was used to screen a kZAP II phage library prepared 
from HeLa cells (cDNA ~ZAPII and ~,gtl 1 libraries were a gift from 
Prof. Chambon, IGBMC, Strasbourg). From this second screening, 
six positive clones were isolated. The nucleotide sequence of each 
DNA insert was determined by primer walking on both strands. 
2.2. Northern blot analysis 
Human I and II multiple tissues Northern blots (MTN) were pur- 
chased from Clontech. Each lane contains a minimum of 2 ~tg of pure 
poly(A) + RNA from human tissues. Radiolabeled probes A or B were 
obtained by PCR from clone 8 and correspond either to the 3' end or 
to the medium part of this clone. Blot hybridizations were performed 
according to the manufacturer's instructions. To normalize the 
mRNA levels, MTN blots were stripped and reprobed with rat 
GAPDH cDNA [17]. The amount of mRNA was quantitated by 
PhosphorImager System (Molecular Dynamics) [18] and were normal- 
ized with data from GAPDH hybridization. 
S0014-5793/96/$12.00 © 1996 Federation of European Biochemical Societies. All rights reserved. 
SSDI  S00 1 4 -5793(96)00099-3  
136 F. Aubry et al./FEBS Letters 381 (1996) 135-139 
A 
1 C IO~ ) kgtI 1 
Clone 24 
Clone 3' (A)d0 
Clone 1' (A)67 
Clone 18 ~ (A) I8  
A 
Clone 22 i 
Clone 8 AUG u*~ 
235 bp 
1044 bp 
2004 bp 
2073 bp 
2265 bp 
2228 bp 
+ + + 3544) bp 
Polyadenylation sites 
B 
cctgggcaccgcca~tt tg  g ga ~a=~tgtgtggctg&aaa~tg&aggca&gagc  -73 ~A OAT GeT TAT ACT CA°  °CA e~ TTT GTG ACe GAT GTA ATG ~ CCT CTG C~A 1350 
g g . . . . . . .  0 . . . . . . . . .  0 . 0  
at t tgscotots~to¢¢otco~a ggato t ta tee  agaagm~tggat  a t tc t  t te gccc  a~t  -1 
. . . .  XC  AITC AT ,  ~T  ¢~%A XG GvTG . . . .  TeA T~A ~S . . . . . . .  EAA . . . . . . . . . .  
ATG GCA GAC A~ TTA ACG AGA ATT  GeT ATT  GTC AAC CAT GAC Rw%A ~T ~ CCT 54 I E I Q ° G G L Q 468 
. . . . . . . . . . . . . . . . . . .  o 
, . . ,u , ,~T cGAc~ ~,u ,~ ~ AnT ~Tccr  a~Aa~ce. , , , x~x~ I08  R v ~[ r. ~" [L  c o ~ l, D V Y L n ,188 
K K C R ° I C K K S C P V V R M G K 36 
GAA °CA TCT OCA TAT TTG OAT TCT GAG CAA ASA CTG ATG GCA GeT CGA GTT GTC 1512 
TTA ~ ATA GAG GTT ~A CCC CAG ~ ~.EA ATA ~A ~ ATT  TCC C~ ACT °TT  162 E P S A Y L n 8 E ° n L M A A R V V 504 
L ¢ I Z V T P ° S K I A W Z S I T L 54 
~T ATT GOT TOT GOT AT°  TOT ATT  ~ R~A ~C CCC T~ ~ ~C ~A ~A ATT 216 K R I B A X K F V V H 522 
C3~ I G C G I ° I n K ~LC 9 F G A L S I 72 
V • L P S • L • K n T T ~ R Y C ^ ~ 90 
GCC T~ ~ CTT  CAC ~ TTG CCT ATe  CCT CGT °CA ~T ~ OTT ~ (W~A TTA 124 K T V A P Q T L L K • SSS 
A • n L H R L P I P R P {~ E V L G L 108 
[~k' ~ ~ uc~G cT~ eaaa  aca  ~ x a ~°  c c ~*~ccac~ 17~8 
C~A R~%G CCA ~C CTT  GGA AAG TAC OAT OAT CCT CCT GAC T~G CAG GAG ATT  TTG 432 I K L D V S G Y 594 
° K P ~ L G K Y D D P P D W Q E I L 144 
~T TAT T~ CGT GGA TCT ~ TTA CAA 929T TRC TTT  AC~ ~ ATT  eTA G~ GAT 48~ F F L D D * 800 
T Y • R G 8 n L g • Y • T K I L • D 182 ctagaat t t t t t~aatat  aaaact  tgaatu&qgmtt t t~t  g=ca~a~at  a~t~t  ggaa~t  t gaag~at  aat 1919 
~c eTA ~AA ~w~C AT°  AT°  ~ CCT C~ TAT GTA ~ C~ ATT  CCT ~ G° -~,CA 340 at&ctt&at&t&ac&taaaaa~ca~ttg~ttct~attgta~tt~aaacm=agmamatgccautttt=tg 1991 
D L X A I I K • Q Y V |D Q I P K] A A 180 
i A R • L Rl t ta~t~a~gagS~t~tt t~&taatat to taa~tg~a~at t t~a&~:t~ta=a~at tao~=~&g 2063 
~OG ~ G~ @GA ~T ATT  T~ U~ °GA ~ ~T ~ ~A J~ ~A °~ GCA 594 
X G T V G S I D D R ~ D n T X T Q A 198 t t t t  cat  qaE~a~gggaaqmt  tEeoa~ag~t  ~t at  t at  at  tcacg~a~=mm~ tg~ga~cagt  ~t~t  2135 
. . . . . . . . . . . . . .  ~D"  ~L  A ~ . . . . . . . . . . . . . . . .  ~ . . . . . . . . . . . . . . . . . . . .  gaaaagg~ . . . .  ~ . . . . . . . .  ggt t tg~aaas~at~ca~aatg  . . . . .  g~ . . . .  
I V C Q ° L S L K E R S V • 218 
cut  t a r t  t t aaaagccagtcaaagmttuuact  gmtt  gacmtt t  ~ataam~c&toaggat  t a t  g t t t  ~t t  22~8 
CTT TeA O~ ~ ~A~ TT~ ~ CT  702 R~A TTT  ~T TOT ~ G/~ GTT ~ ATA CAG P.EA 
~L  8 G G • L R F A C V V C Z K 234 Q %~t t ~t t tca%~ct  t t )aot  at  ta t too  a~at  a tg~ttc=la~aml~tt  &totact~aaaaomc=m 235~ 
~T GAT ATT  TTC ATG TTT OAT GAG CCT TCT AOT T~ eTA OAT GTC RAG C~ CGT 755 ct~tg~a~aat~q~tt t t taaat tg~tt t t~t~t t t t tg~9~tt t taa*~atS~t~aaaa 24Z3 
A o I • M F n E P s s Y L D v K Q n 2~z R 
acca~ca~t~cattmoo°gcaaa~aacoc~taa°tttactctgaaottttttt~ttttg°att¢~at 9 2495 
TTA A~G GeT ~T ATT  ACT ATA C~ TCT CTA ATA ~T CCA ~T AGA TAT AT°  ATT  810 
L • A A I T I R s L I R P D R Y I I 270 ag~t~ t ~rnat t cage°  a te° to t  ag~a&t  ~t~ &t t t  t t  ~t &~ a~at  a t&t t t&t  ata~ tu a~ t g&t t g&g 2567 
V V • H D L 8 V L D Y L S D F I C C 288 
go¢taagoatQtat~at t t t t t t taag~t==a~agat t t t to t~tggg°m~aaggmttataaaocac  2711 
TTA TAT  ~T GTA °CA AGe ~C TAT C~A GTT O~ ACT ATG CCT TTT  ~T OTA AUA 918 
L Y O V P S a Y G V V T M S • S V R SOS t teeutaaaq~aau*t taatg=aaaag~uou=agatggcaateoaaag~atoo~tq~aooaaatatat t  2783 
G~% G~ ATA ~ ATT  TTT T~ OAT (~ TAT  GTT  CCA ACA n~ ~%c TT~ AOA TTC 972 ¢ittt~tga~tttgg~tmtagm~acmt~mtc~aaac=mttttg~a~t=ollal&=c~at=taaattt~tt 2855 
• G i m I • L o G Y v P T • m L R r 324 
ga g~tcct  ge a t t t tg~ acaggat  tmoo~ggag¢=tgga~°  a° t t taa  ~t  g~act  rut  gm°t  aa act  gga 2917 
~A C~T ~W~A T~A °TT  GTT  TTT  ~ GTG ~T ~ R~A GCA AAT ~ G~ ~ GTT 1026 
R D A s L v F K v A • T A S E E • v 342 • t U~ t f .~gaggaaqm~nt  m=~a~ata~atga=t~ a a g~ama ~t gagg~qgaaat  t agaaa~t  2999 
J~G AT~ ~T A~ TAT ~ TAT c~ ~ ATG ~AG J~ ~ ATG ~GA ~ TTT  1080 ~t tgmaaaaut t~magmg~tact tgaaataaoaqaagtc t~gat~aata~gcaaa~aaeggc~agaaag~.  3071 
K K M c 14 Y K Y P o 14 I( X K N ~ • r 380 
t ~gt t t ~aet~accc~at  t me°cot  t t t ~ama. t  aat tuca~ ~uuu ~t ~.at  ~°at  get  ~a. .aaat  t 5143 
GAG eTA ~A ATT  OTA ~T ~C~ OAO ~Z~ ACA GAT TCT G~ ATT  ATG O1~ AT~ C~ 1134 
• L A I V A ~ z • T D s • I N v M L 37~ ua aat at  m=agaat  ~a~am~a~t  gaEct  ooo~t  a~t ~°~¢t=¢~m aag~ta¢¢~c ~t t  ga~.~tt 3215 
GG~ GAA AAT GGA ACG GGT ~ A~G ACA TTT  AT°  A~A ATG CTT  GeT GGA AGA CTT  1188 eataat~atat to t t tcat~f~t t t t t t=t~a=tteoota~gmmtat~aamgg~tt~t t t~ 3287 
T • I R M L A G n L 596 
at ~camat  g~gat ta taotmammtma~tgco~at t t t t  ~oqataq~tmmmtt t~tg&at )a tcat t t  5359 
) OCT ~T ~ NA ~A ~ GTA C~ GTT CTA ~T GTC AGT TAT  ~ CCA CAG 1242 ~t taotgatcotg(&)431 
K P O • G l • V P V L i V S Y K P Q 414 a la l t  i t  i t  t g~t~m~t  mmg~malm~t  °t  t ~t  ~a ] ¢ ~  3397 
ATT  AnT  CCC ~ TeA ACT ~ R~T GTT CC~ CAG TTA eTA CAT G~ ~ ATA 1296 
K I S P K S T G S V R ° L L B • K I 432 
Fig. 1. Cloning of full-length RLI cDNA. (A) A first clone was isolated by immunoscreening of a Lgtll library and was designated as clone 
3%gtll. Using the 235 bp radiolabeled cDNA corresponding to the clone 3%gtl 1 insert, six positives clones were isolated from a %ZAPII li- 
brary. Clones 1', 3' and 18 have polyadenylation tails of different length. Clone 8 is the largest and corresponds to the complete coding se- 
quence of RLI cDNA. It contains the first in-frame ATG codon, a stop codon UAG (marked with asterisk) and four polyadenylation sites (in- 
dicated by arrows). Probes A and B, obtained by PCR from clone 8, are used to detect specific transcripts. (B) Clone 8 cDNA and the 
deduced amino acid sequence are aligned with RLI sequences. Nucleotides and amino acids indicated by open boxes correspond to differences 
with the sequence described by Bisbal et al. [15]. The position of nucleotides and amino acids is indicated by numbers on the right. Stuctural 
motifs include consensus equence for iron-sulfur binding (delimited by arrow), the two P-loop motifs (indicated by shadowed boxes) and the 
duplicated consensus pattern of the ATP-binding proteins family (within brackets). Polyadenylation signal sequences are underlined and the 
ATTTA putative instability sequences are double underlined. 
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2.3. Southern blot analys& 
Human genomic DNA was prepared from blood and digested with 
EcoRI or HindIII. Southern blots were hybridized with a c~-32p-la - 
belled probe corresponding to clone 8. All these procedures have been 
performed as described by Sambrook et al. [19]. 
2.4. Chromosomal in situ hybridization 
In situ hybridization was carried out on metaphase chromosome 
preparations according to our method previously described [20]. The 
clone 8 pBluescript was tritium-labeled and used as probe. 
3. Results and discussion 
3.1. Isolation and characterization of  seven distinct overlapping 
cDNA clones 
In order to identify a new proliferation-associated nuclear 
antigen, we screened a ~,gtl 1 expression library of the MCF7 
cell line using a previously described monoclonal murine B1N 
[21,22]. Three different clones have been identified in the 
course of immunoscreening. One of these (clone 3 )~gtll) 
was used to screen a )~ZAP library of the Hela cell line by 
plaque hybridization to obtain full-length eDNA. This second 
screening allowed us to isolate six additional independent po- 
sitive clones. 
Sequence analysis of the seven cDNA fragments has shown 
that they are overlapping (Fig. 1A). Three clones (3', 1', 18) 
have the same 3' end displaying a stretch of respectively 40, 67 
and 18 adenine residues, preceded by the putative polyadeny- 
lation signal AATAAA. The largest one, clone 8, comprises 
3540 pb in length and possesses three other putative polyade- 
nylation signals but no polyadenylation tail. This sequence 
contains a single open reading frame encoding a 599 amino 
acid (aa) protein with a calculated pI of 8.3 and a molecular 
weight of 67.3 kDa (Fig. 1B). 
Quite recently, a similar eDNA sequence, differing from our 
cDNA sequence at some nucleotide positions in both the cod- 
ing and non-coding sequences, has been reported by Bisbal et 
al. [15]. This cDNA encodes a potent inhibitor designated as 
RLI (for RNAse L inhibitor). Our eDNA is 20 nucleotides 
longer at the 5'-unstranslated end (Fig. 1B). The first in-frame 
ATG is preceded by an in-frame translational stop codon and 
is in a favorable Kozak environment [23], indicating that it 
corresponds to the translation i itiation codon. This sequence 
has been confirmed in three other small independent clones 
isolated during a third screening (data not shown). 
Sequence comparison of clone 8 and H2ABP cDNAs de- 
scribed by Bisbal et al. [15] reveals several nucleotide differ- 
ences in the coding region at positions 352, 1411, 1412, 1417, 
1418 in Fig. 1B, inducing amino acid substitutions at posi- 
kb 
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Fig. 2. Northern blot analysis of RLI transcripts. MTN I was hy- 
bridized with the cx-32p-labeled probe A (part A) or probe B (part 
B). The position of the RNA size markers is shown on the left side. 
Lanes: 1 =spleen; 2=thymus; 3=prostate; 4=testis; 5a and 
5b = ovary; 6 = small intestine; 7= colon; 8 = peripheral blood leuko- 
cyte. 
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tions 118, 471 and 473. Futhermore, an additional A at posi- 
tion 521 and the absence of G at position 538 in clone 80RF  
explain the divergence of five amino acids residues (aa 174- 
178). Other differences are observed at the 5' and 3' untrans- 
lated ends. In particular, the last five nucleotides of clone 8 
differ from those of clone H2ABP (Fig. 1B). Since we care- 
fully checked our original sequence data on several overlap- 
ping clones, errors should be excluded in our sequence. The 
persistent discrepancies might reflect either natural poly- 
morphism or a cloning artefact. 
The predicted amino acid sequence contains a ferredoxins 
iron-sulfur binding region signature CX(2)-CX(2)-CX(3)-C- 
(PEG) [24,25] (aa 55 65 in Fig. 1B) and a P-loop consensus 
motif (G/AXXXXGKS/T) [26] at two positions (aa 110-i 17; 
379-386), already mentioned by Bisbal et al. [15]. In addition, 
we found an ATP-binding site (aa 217-228) with the consen- 
sus pattern: (LIVMFY)-S-(SAG)-GX(3)-(RKA)-(LIVMYA)- 
X-(LIVMF)-(SAG). A duplicated form of this conserved re- 
gion is also found at positions 462473. A P-loop motif is 
often associated with this ATP-binding region in the ATP- 
binding cassette (ABC) of the transporter protein superfamily 
[27]. These proteins are involved in a variety of distinct bio- 
logical processes, but most of them are involved in active 
transport of small hydrophilic molecules across the cytoplas- 
mic membrane. However, they share a conserved omain of 
about 200 amino acids including the ATP-binding site. De- 
spite the absence of this domain in RLI, we are faced with the 
question of the significance of the simultaneous presence of 
these duplicated sequences and of the P-loop motif. We hy- 
pothesize that this protein has an ATP-dependent activity. 
This idea could be compatible with the observation that 
ATP stimulates at least the 2-5A-dependent RNase activity, 
probably by stabilizing the active form of the enzyme [13]. 
3.2. Distribution of  RL l  mRNAs  & various adult human tissues 
by Northern blot analysis 
Poly(A) + mRNAs from various human tissues were ana- 
lysed by using probes A and B (Fig. 1A). As shown in Fig. 
2, probe B, the sequence of which is shared by clones 1', 3' 
and 18, detects two mRNA species of 3.8 kb and 2.4 kb, while 
probe A, specific for the 3' end (clones 22 and 8), hybridizes 
only to the larger mRNA (see ovary lane in Fig. 2). Thus on 
the one hand, the cDNA determined from the 5' end of clone 
8 up to the 3' end of clones 3', 1' and 18 probably corre- 
sponds to the small mRNA (2419 pb without the poly(A) 
tail), confirming that the first polyadenylation site (position 
2255) is biologically active. On the other hand, clone 8 (3540 
bp) most probably corresponds to the large 3.8 kb mRNA. 
We can conclude that the polyadenylation signal located 25 
bp upstream of the 3' end of clone 8 (position 3371) is also 
active in vivo, although no polyadenylation tail has been 
found on this clone. This location is in agreement with the 
position already described in eucaryotes cDNA [28]. 
To evaluate the expression level of the two specific mRNAs, 
multiple tissue Northern blots were successively analysed with 
PCR probe B and with a glyceraldehyde-3-phosphate deshy- 
drogenase (GAPDH) probe as control. This enzyme is consti- 
tutively expressed in most tissues, except in fast twitch muscle 
where it can be induced to high levels [29]. This is the reason 
why values from heart and skeletal muscles have not been 
taken into account for comparative analyses. 
As shown in Fig. 3A and B, both mRNAs (3.8 kb and 
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2.4 kb) are present in various tissues, but at different levels 
suggesting a transcriptional nd/or post-transcriptional regu- 
lation. The 2.4 kb transcript is generally less abundant than 
the 3.8 kb, except in skeletal muscle and testis, where they 
have equivalent levels (Fig. 1A). Peripheral blood leukocytes, 
for example, show a lower 3.8 kb mRNA level and a dramatic 
decrease in 2.4 kb mRNA. Sequence data have shown that the 
two mRNAs differ in the length of their 3'-unstranslated end. 
There is evidence that the 3'-untranslated regions are involved 
in mRNA stability through secondary structure and protein 
RNA interactions, both elements being also able to control 
translation initiation at the 5' end [30-32]. Interestingly, 4 
putative instability ATTTA sequences are detected in the 3' 
untranslated nd (Fig. 1B). Two of them are absent from the 
small transcript, suggesting differences in the decay rate of the 
two mRNAs. However, both transcripts encode the same RLI 
protein, the ratio difference between the two mRNAs and 
their biological and functional signification eeds to be eluci- 
dated. It can be noted that the 3.8 kb mRNA is expressed to a 
lesser extent in non-proliferating tissues, such as brain, per- 
ipheral blood leukocyte and kidney, than in ovary and testis, 
A 
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known to have a high proliferative index. The pattern of 2.4 
kb mRNA distribution is similar, except in testis, where 2.4 
kb mRNA is overexpressed. In this tissue, high levels of both 
mRNAs are available for translation. 
3.3. Genomic blot analysis and chromosome mapping 
Southern blot analysis of human leukocyte genomic DNA 
was performed using ~-3zP-labelled clone 8 cDNA in pBlue- 
script vector as probe. Genomic DNA was digested with 
EcoRI or HindIII restriction endonuclease. Hybridization re- 
vealed 6 HindIII fragments and 10 EcoRI fragments of equal 
intensities indicating more likely a single copy gene per hap- 
loid genome (data not shown). As the whole cDNA probe has 
no such restriction site, RLI gene should be splat in at least 
ten exons. However, the existence of a second gene or a pseu- 
dogen cannot be fully excluded. 
Chromosomal localization of the RLI gene was determined 
by in situ hybridization with clone 8 cDNA probe on meta- 
phase chromosome spreads from phytohemagglutinin-stimu- 
lated human peripheral blood lymphocytes. In the 100 meta- 
phases examined, 34 of 155 silver grains (21.9%) were located 
~3.8  kb 
2.4 kb 
~1.3  kb 
B 
0.8] [U]2.4 kb mRNA [ Im 
0.6 
0,4 
0.3 
0.2 
Fig. 3. Relative distribution of 3.8 kb and 2.4 kb mRNA in various human tissues by Northern blot analysis. (A) MTN I and II were hybri- 
dized with the ¢t-a2P-labeled probe B (a) or with a GAPDH probe as normalizing control (b). (B) The resulting histogram represents relative 
abundance of RLI transcripts in growing expression order in various human tissues. These relative values were estimated from the ratio of 
data obtained with specific mRNA (3.8 kb or 2.4 kb) to GAPDH mRNA. 
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Fig. 4. Chromosomal localization of the RLI gene by in situ hybri- 
dization. Ideogram of the human G-banded chromosome 4 illustrat- 
ing the distribution of labeled sites for the RLI gene probe with the 
maximum concentration of silver grains at locus 4q31. 
on the long arm of chromosome 4 in the q31 region (Fig. 4). 
These results allow us to map the RLI  gene to 4q31 band of 
the human genome. 
Region q31 has been shown to be involved in translocation 
associated with a form of oculocutaneous albinism [33]. The 
RLI  probe might constitute a physical mapping tool for chro- 
mosome 4 region q31 analysis. Because of the localization of 
the small forms of 2-5A synthetase in human chromosomes 11 
[34] and 12 [35], and of 2-5A-dependent RNase gene RNS4 in 
human chromosome 1 [36], the genes for these different en- 
zymes in the 2-5A system and RNase L inhibitor do not 
appear to form a gene cluster system in the human genome. 
Immunoscreening with the previously described monoclonal 
antibody B1N allowed us to isolate and sequence several 
cDNAs. Surprisingly, these cDNAs correspond to three sets 
of mRNAs  coding for three different proteins: HSP90 [37], an 
unknown protein bearing some similarities to the helicase fa- 
mily (manuscript in preparation) and RLI. To substantiate 
which one of the cDNAs encodes the authentic B1N protein, 
we are currently preparing polyclonal antibodies against a 
bacterially expressed part of each polypeptide deduced from 
isolated cDNAs. These antibodies are expected to show in 
immunoblot and immunohistochemical assays staining pat- 
terns identical to those obtained with monoclonal antibody 
B1N [21,22]. I f  the B1N antigen does indeed correspond to 
the RLI  protein, polyclonal and especially monoclonal anti- 
bodies will constitute a usefull tool to study the role of RLI  in 
the 2-5A pathway. 
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